ArticleSurgical case reports2026
Improvement of Suspected Paraneoplastic Large-Vessel Vasculitis after Breast Cancer Resection: A Case Report.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionParaneoplastic vasculitis is an uncommon manifestation of malignancy and has been reported mainly in association with lung cancer, renal cell carcinoma, and hematologic malignancies. Breast cancer-associated vasculitis is rare, and presentation as large-vessel vasculitis (LVV) is particularly uncommon. We report a rare case of suspected paraneoplastic LVV occurring concurrently with breast cancer, in which inflammatory activity stabilized after surgical resection of the primary tumor. CASE PRESENTATION: A 54-year-old woman presented with pain in the left upper limb and left thigh. CT suggested left breast cancer with ipsilateral axillary lymph node metastasis. PET/CT showed fluorodeoxyglucose uptake in the left breast lesion and left axillary lymph node, as well as in multiple large vessels, including the carotid arteries, subclavian arteries, aorta, iliac arteries, and femoral arteries. Laboratory testing revealed an elevated C-reactive protein level of 10.93 mg/dL, whereas immunoglobulin A and antineutrophil cytoplasmic antibodies were within the normal ranges. There was no evidence of infection, autoimmune disease, or drug-induced vasculitis. Because breast cancer-associated paraneoplastic LVV was suspected, prednisolone was initiated at 30 mg/day, resulting in rapid improvement in symptoms and inflammatory response. The patient subsequently underwent breast-conserving surgery with axillary lymph node dissection while receiving prednisolone at 15 mg/day. Pathological examination revealed invasive ductal carcinoma, pT1c pN1 cM0, stage IIA, luminal A subtype. After surgery, prednisolone was tapered to 5 mg/day without recurrence of vasculitis, and inflammatory activity remained controlled during follow-up.
conclusionsLVV occurring concurrently with newly diagnosed breast cancer may represent a paraneoplastic manifestation after exclusion of autoimmune, infectious, and drug-induced causes. This case suggests that tumor resection may contribute to stabilization of inflammatory activity by reducing tumor-related antigenic or cytokine-mediated stimulation. Surgical treatment may therefore have a potential role not only in local oncological control but also in the management of paraneoplastic immune dysregulation in selected patients with resectable breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.